bimatoprost sr
bimatoprost sr: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: AbbVie Inc. (ABBV)
Development Pipeline (1)
| Company | Phase |
|---|---|
| AbbVie Inc. (ABBV) | Phase 3 |
Clinical Trials (1)
An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients With Open Angle Glaucoma or Ocular Hypertension
Frequently asked questions
Who is developing bimatoprost sr?
bimatoprost sr is being developed by AbbVie Inc..
How many clinical trials involve bimatoprost sr?
BioSniper tracks 1 clinical trial involving bimatoprost sr.
Analyze AbbVie Inc. & bimatoprost sr with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company